Piper Sandler Maintains Overweight Rating for Inspire Medical Systems: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Piper Sandler has maintained its Overweight rating for Inspire Medical Systems (NYSE:INSP) and raised its price target from $315 to $340, representing an 11.92% increase from the current share price. Inspire Medical Systems focuses on minimally invasive solutions for patients with obstructive sleep apnea.
June 08, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler maintains Overweight rating for Inspire Medical Systems and raises price target from $315 to $340, an 11.92% increase.
The maintained Overweight rating and increased price target by Piper Sandler for Inspire Medical Systems indicate a positive outlook for the company's stock. This news is likely to boost investor confidence and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100